Suhagra 50 mg Tablet – Sildenafil for Erectile Dysfunction

Product Description

Suhagra 50 mg Tablet is a pharmaceutical product containing sildenafil, a medicine belonging to the phosphodiesterase type 5 (PDE5) inhibitor class. According to the supplied product information, each tablet contains sildenafil 50 mg, and the product is listed in a pack of four tablets. Cipla Ltd is identified as the marketer in the provided source. **Composition and Formulation** The stated active ingredient is sildenafil at a strength of 50 mg per tablet. The dosage form is an oral tablet intended to be swallowed according to the prescribing instructions. Other formulation details, including inactive ingredients, tablet dimensions, colour and storage conditions, are not specified in the supplied information and should be verified against the product packaging or official prescribing documentation. **Therapeutic Use** Sildenafil is prescribed for the management of erectile dysfunction in eligible adult men. It belongs to the PDE5 inhibitor class and works by supporting the nitric oxide–cyclic guanosine monophosphate pathway, helping relax smooth muscle and increase blood flow in penile tissue during sexual stimulation. Sexual stimulation is necessary for its effect on erections. The medicine does not independently increase sexual desire. Suhagra 50 mg should be used only when prescribed by a qualified healthcare professional. The appropriate dose and timing depend on the patient's medical history, other medicines and individual clinical circumstances. Patients should not increase the dose, repeat a dose or combine it with other erectile dysfunction medicines without medical advice. **Packaging and Product Identification** The supplied listing identifies Suhagra 50 Tablet as a four-tablet pack. Cipla Ltd is named as the marketer, while the product is listed under the Suhagra brand. The exact packaging material, manufacturing facility, country of origin, batch-specific expiry date and complete ingredient list are not established by the provided information. These details should be checked against the original packaging and current product documentation. **Safety and Precautions** Sildenafil can interact with nitrate medicines, including certain medicines prescribed for chest pain, and may cause a dangerous fall in blood pressure. Interactions with other medicines are also possible. People with cardiovascular conditions, low blood pressure, significant liver or kidney problems, or a recent history of serious cardiovascular events should consult their healthcare professional before treatment. Commonly reported adverse effects include headache, facial flushing, dizziness, indigestion and visual disturbances. Sudden vision or hearing loss, chest pain or an erection lasting more than four hours requires urgent medical attention. Patients should avoid driving if they experience dizziness or visual disturbances and seek medical advice about alcohol consumption. **Procurement and Verification** Pharmaceutical distributors and eligible buyers should verify the brand, sildenafil strength, pack configuration, marketer details, batch number, expiry date and applicable regulatory documentation before procurement. The supplied source identifies Cipla Ltd as the marketer, but the manufacturing facility and batch-specific authenticity have not been independently verified. Use reliable documentation to confirm product identity and regulatory status before publication or supply.

Additional Product Details

No additional product details available.

Product Specifications

Business Information